GLP-1 Calms His ADHD

Interesting question I saw on the interwebs- 

I have a friend who has been taking GLP1 injections for nearly a year now. He had lost some weight (though that had plateaued and he is still overweight), but the most salient effect is that it calms his ADHD. Have you also seen this effect in your patients? If so, what could be the physiology of this?

Here’s my answer:

It is completely normal that your friend’s weight loss has stalled, but his experience with his ADHD symptoms is a fascinating reflection of how these drugs impact the central nervous system.

Here is the physiology behind what is happening:

1. GLP-1 Acts Directly on the Brain

While we often think of GLP-1 as a digestive hormone secreted by the gut, GLP-1-secreting cells and receptors are actually expressed abundantly throughout the brain. When you take a GLP-1 agonist, the drug crosses into the brain and actively targets the neural pathways responsible for hunger, cravings, and reward.

2. The ADHD and Dopamine Connection

ADHD is fundamentally tied to dysregulation in the brain’s pleasure centers and low activity in the prefrontal cortex (the brain’s “supervisor”), which are driven by the neurotransmitter dopamine. Dopamine is critical for motivation and paying attention. Because individuals with ADHD often have low dopamine levels, their brains constantly seek out external thrills or stimulation just to feel satisfied or to maintain focus. This creates the restlessness and impulsivity characteristic of the disorder.

3. Calming the Brain’s Reward Circuits

GLP-1 medications actively interfere with these exact reward brain circuits. By dampening the brain’s reward-seeking pathways, GLP-1 drugs are known to turn down constant “food noise” and cravings. Accumulating clinical evidence shows these drugs have powerful weight-loss-independent benefits on other dopamine-driven comorbid conditions, successfully reducing symptoms of substance use disorders and binge-eating disorders.

In short, by acting on the brain’s reward centers, the GLP-1 injection is likely dampening your friend’s hyperactive drive for dopamine stimulation. Just as the drug quiets the “noise” and compulsions related to food, it appears to be quieting the broader stimulation-seeking drives of his ADHD, resulting in a profound calming effect.

Regarding His Weight Loss Plateau 

You mentioned that he has plateaued and is still overweight, which is the expected trajectory for these medications. Clinical trials for GLP-1 drugs (like semaglutide and tirzepatide) show that weight loss reliably plateaus after about a year (around 65 weeks).

This happens because the human body fights back against the drug’s calorie deficit. As a person loses weight, their body requires fewer calories to function, while simultaneously ratcheting up the hunger drive to resist further weight loss. Eventually, this biological resistance matches the effects of the drug, and weight loss stops. As your friend has experienced, even on the highest doses, many participants remain in the overweight or obese categories at this plateau.

Read How to Naturally Boost GLP-1.